Walgreens Boots Alliance, Inc. (WBA) Shares Sold by TCI Wealth Advisors Inc.

TCI Wealth Advisors Inc. lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.1% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 12,711 shares of the pharmacy operator’s stock after selling 17 shares during the period. TCI Wealth Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $995,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Hudock Capital Group LLC lifted its holdings in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares in the last quarter. Modera Wealth Management LLC lifted its holdings in Walgreens Boots Alliance by 0.4% during the 1st quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock worth $204,000 after buying an additional 9 shares in the last quarter. Flagship Harbor Advisors LLC lifted its holdings in Walgreens Boots Alliance by 0.5% during the 1st quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock worth $243,000 after buying an additional 16 shares in the last quarter. Sowell Financial Services LLC lifted its holdings in Walgreens Boots Alliance by 0.6% during the 1st quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock worth $218,000 after buying an additional 17 shares in the last quarter. Finally, WealthTrust Arizona LLC lifted its holdings in Walgreens Boots Alliance by 0.4% during the 2nd quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock worth $412,000 after buying an additional 21 shares in the last quarter. Institutional investors own 63.79% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://sportsperspectives.com/2017/11/12/walgreens-boots-alliance-inc-wba-shares-sold-by-tci-wealth-advisors-inc.html.

A number of equities research analysts have issued reports on the stock. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday. UBS AG restated a “buy” rating and issued a $96.00 price objective (down from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. Royal Bank Of Canada began coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective on the stock. Citigroup Inc. reduced their price objective on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a report on Thursday, November 2nd. Finally, Jefferies Group LLC restated a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, October 2nd. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $87.63.

Walgreens Boots Alliance, Inc. (WBA) opened at $70.99 on Friday. Walgreens Boots Alliance, Inc. has a 52-week low of $63.82 and a 52-week high of $88.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. The stock has a market cap of $70,204.04, a price-to-earnings ratio of 13.64, a price-to-earnings-growth ratio of 1.24 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The company had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same period last year, the firm posted $1.07 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 5.3% on a year-over-year basis. equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.25%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is currently 42.33%.

Walgreens Boots Alliance announced that its board has approved a share repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback programs are typically an indication that the company’s management believes its shares are undervalued.

In other news, Director John Anthony Lederer bought 20,000 shares of the stock in a transaction dated Thursday, October 26th. The shares were acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply